Donald Trump’s pick to lead U.S. health agencies, petitioned the FDA to revoke authorization of the shots at a time when they were in high demand and considered life-saving. Read more
CDP Lower House lawmaker Kazuhiro Haraguchi has said that the drugmaker’s replicon vaccine is “akin to a biological weapon.” Read more
U.S. President-elect Donald Trump’s picks to lead the nation’s top public health agencies also don’t inspire confidence. Read more
The revised timeline allows eligible women to receive their first dose by the end of March 2025 and complete the remaining two within the following year. Read more
The program mainly targets people age 65 or older. It began on Tuesday and will run until March 31 next year. Read more
Airstrikes on two former schools that were housing displaced people, one in Gaza City and one in Jabalia, killed at least 12 people, Palestinian medics said. Read more
The numerous unknowns about the virus itself, its severity and how it is transmitting, is complicating the response. Read more
The slow arrival of the shots — available in many places outside Africa — showed that lessons from COVID-19 about global health care inequity must still be learned. Read more
Traditionally, organizations like Gavi, which helps lower-income countries buy vaccines, can only start purchasing shots once they have approval from the WHO. Read more
The health ministry has told municipalities to ensure a stable supply of measles shots for children amid a surge in demand for the vaccine following recent small outbreaks in Japan. Read more
